211 related articles for article (PubMed ID: 34592958)
21. Preliminary investigation on the abnormal mechanism of CD4
Liu SX; Xiao HR; Wang GB; Chen XW; Li CG; Mai HR; Yuan XL; Liu GS; Wen FQ
Exp Ther Med; 2018 Aug; 16(2):1433-1441. PubMed ID: 30116392
[TBL] [Abstract][Full Text] [Related]
22. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
[TBL] [Abstract][Full Text] [Related]
23. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
24. Correlations between Circulating and Tumor-Infiltrating CD4
Al-Mterin MA; Murshed K; Elkord E
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455287
[TBL] [Abstract][Full Text] [Related]
25. Regulation of CD4
El-Maadawy EA; Elshal MF; Bakry RM; Moussa MM; El-Naby S; Talaat RM
Mol Immunol; 2020 Aug; 124():1-8. PubMed ID: 32480291
[TBL] [Abstract][Full Text] [Related]
26. Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus.
He W; Hao S; Dong X; Zhang D; Jia Z
Biomol Biomed; 2023 Feb; 23(1):53-62. PubMed ID: 35801423
[TBL] [Abstract][Full Text] [Related]
27. Induction of stable human FOXP3
Cook L; Reid KT; Häkkinen E; de Bie B; Tanaka S; Smyth DJ; White MP; Wong MQ; Huang Q; Gillies JK; Ziegler SF; Maizels RM; Levings MK
Immunol Cell Biol; 2021 Sep; 99(8):833-847. PubMed ID: 33929751
[TBL] [Abstract][Full Text] [Related]
28. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
[TBL] [Abstract][Full Text] [Related]
29. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
30. Correlations between Circulating and Tumor-Infiltrating CD4
Al-Mterin MA; Murshed K; Elkord E
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146549
[TBL] [Abstract][Full Text] [Related]
31. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
[TBL] [Abstract][Full Text] [Related]
32. Determination of a CD4+CD25+ Foxp3+T cells subset in Egyptian Colorectal Cancer Patients.
Elsheshtawy NM; Saad M; El-Ghamrini YM; Ziada KW
Egypt J Immunol; 2021 Jul; 28(3):145-156. PubMed ID: 34453786
[TBL] [Abstract][Full Text] [Related]
33. CD4+CD25+ regulatory T cells in tumor immunity.
Chen X; Du Y; Lin X; Qian Y; Zhou T; Huang Z
Int Immunopharmacol; 2016 May; 34():244-249. PubMed ID: 26994448
[TBL] [Abstract][Full Text] [Related]
34. T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.
Kalathil SG; Lugade AA; Pradhan V; Miller A; Parameswaran GI; Sethi S; Thanavala Y
Am J Respir Crit Care Med; 2014 Jul; 190(1):40-50. PubMed ID: 24825462
[TBL] [Abstract][Full Text] [Related]
35. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
[TBL] [Abstract][Full Text] [Related]
36. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer.
Khalife E; Khodadadi A; Talaeizadeh A; Rahimian L; Nemati M; Jafarzadeh A
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3019-3025. PubMed ID: 30484986
[TBL] [Abstract][Full Text] [Related]
38. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
[TBL] [Abstract][Full Text] [Related]
39. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
[TBL] [Abstract][Full Text] [Related]
40. [Effect of semaphorin-3A on the cellular stability of CD4
Gao Y; Li L; Liu Y; Li W; Wang Z; Shou S; Chai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1454-1460. PubMed ID: 33541497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
